journal article Open Access Nov 27, 2023

Direct oral anticoagulants in skin surgery: a systematic review of their complications and recommendations for perioperative management

View at Publisher Save 10.1111/ijd.16916
Abstract
AbstractIntroductionMany patients undergoing cutaneous surgery are prescribed at least one anticoagulant or antiplatelet agent. With the recent emergence of direct oral anticoagulants (DOACs), there is a deficit of knowledge regarding optimal perioperative management. This review aims to evaluate the evidence and risk surrounding management of DOACs in patients undergoing skin surgeries.MethodsSystematic review of EMBASE, Scopus, and PubMed, with inclusion of studies that detailed perioperative management of DOACs in those undergoing skin surgery. Primary outcome measures were perioperative hemorrhagic and thromboembolic complications.ResultsSeven thousand seven hundred and forty‐one abstracts were identified, with 13 articles meeting inclusion criteria. Two studies investigated complication risk associated with DOAC continuation in skin surgery and found an average rate of hemorrhagic complications of 1.74%. Two studies evaluated complications associated with DOAC cessation prior to skin surgery, with a pooled thromboembolic complication rate of 0.15%. Articles comparing continuation and cessation discovered no decreased risk of bleeding with DOAC cessation prior to surgery (P = 0.93). Seven of the 13 articles compared complications in a control vs a DOAC group undergoing cutaneous procedures. Evidence was conflicting but may have suggested a small increase in bleeding risk in those on DOAC therapy.ConclusionOptimal management of anticoagulants perioperatively is difficult because of conflicting information, complicated by advent of novel agents. Risk of hemorrhagic complications with both continuation and interruption of DOAC therapy was low. Perioperative DOAC management can be guided by procedural bleeding and patient clotting risk and can often be continued in minor dermatologic procedures.
Topics

No keywords indexed for this article. Browse by subject →

References
37
[2]
World Health Organisation (WHO)Radiation: Ultraviolet (UV) radiation and skin cancer.2017. [cited 2023 March 03].https://www.who.int/news‐room/questions‐and‐answers/item/radiation‐ultraviolet‐(uv)‐radiation‐and‐skin‐cancer
[3]
2020 Melanoma Skin Cancer Report.Melanoma Research Foundation.2020[cited 2023 March 17].https://melanomapatients.org.au/wp‐content/uploads/2021/09/2020‐campaign‐report‐GC‐version‐MPA_1.pdf
[5]
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al.

New England Journal of Medicine 10.1056/nejmoa1009638
[7]
National Institute for Health and Clinical Excellence.Clinical knowledge summaries: anticoagulation–oral.2016[cited 2023 March 15].http://cks.nice.org.uk/anticoagulation‐oral
[10]
Bray A (2016)
[13]
Scherer DF "Risk of complications due to antithrombotic agents in cutaneous surgery: a systematic review and meta‐analysis" J Dtsch Dermatol Ges (2021) 10.1111/ddg.14579
[14]
Wells G (2013)
[21]
Langan EA "The risk of deep venous thrombosis associated with inpatient dermatological surgery – a prospective pilot study" J Dtsch Dermatol Ges (2021) 10.1111/ddg.14500
[23]
Artamonova I "Postoperative complications in dermatological patients undergoing microscopically controlled surgery in inpatient setting (next‐day surgery): a single‐center epidemiological study" J Dtsch Dermatol Ges (2020) 10.1111/ddg.14148
[25]
Arguello‐Guerra L "Incidence of complications in dermatological surgery of melanoma and non‐melanoma skin cancer in patients with multiple comorbidity and/or antiplatelet‐anticoagulants. Five year experience in our Hospital" Cir Cir (2019)
[35]
Scherer FD "Perioperative management of antithrombotic drugs in skin surgery ‐ A survey of dermatologists in Germany" J Dtsch Dermatol Ges (2022) 10.1111/ddg.14758
[36]
Han J "Distinct approaches to perioperative management of anticoagulation and antiplatelet therapy among providers performing cutaneous surgery" J Drugs Dermatol (2022)
Metrics
4
Citations
37
References
Details
Published
Nov 27, 2023
Vol/Issue
63(4)
Pages
413-421
License
View
Cite This Article
Patrick A. Ireland, Luca Borruso, Sascha K. R. Spencer, et al. (2023). Direct oral anticoagulants in skin surgery: a systematic review of their complications and recommendations for perioperative management. International Journal of Dermatology, 63(4), 413-421. https://doi.org/10.1111/ijd.16916